Compensating for literature annotation bias when predicting novel drug-disease relationships through Medical Subject Heading Over-representation Profile (MeSHOP) similarity

BMC Medical Genomics

Volumn 6, Issue SUPPL2, 2013, Pages

  Cheung, Warren A ^a,b   Ouellette, Bf Francis ^c,d   Wasserman, Wyeth W ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIBLIOMETRICS; DRUG REPOSITIONING; DRUG RESEARCH; INFORMATION RETRIEVAL; MEDICAL LITERATURE; MEDICAL SUBJECT HEADING OVERREPRESENTATION PROFILE; MEDICAL SUBJECT HEADINGS; MEDLINE; PRIORITY JOURNAL; PUBLICATION;

COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; DISEASE; DRUG DESIGN; DRUG REPOSITIONING; HUMANS; INFORMATION STORAGE AND RETRIEVAL; MEDICAL SUBJECT HEADINGS; MEDLINE; PERIODICALS AS TOPIC; PHARMACEUTICAL PREPARATIONS;

EID: 84877358657     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-6-S2-S3     Document Type: Article

References (29)

1. Drug repositioning: identifying and developing new uses for existing drugs. Ashburn TT, Thor KB, Nature reviews Drug discovery 2004 3 673 83 10.1038/nrd1468 15286734 (Pubitemid 39173508)
2. Exploiting drug-disease relationships for computational drug repositioning. Dudley JT, Deshpande T, Butte AJ, Brief Bioinform 2011 12 303 311 10.1093/bib/bbr013 21690101
3. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, Schacht AL, Nature reviews Drug discovery 2010 9 203 14 20168317
4. Drug repurposing and adverse event prediction using high-throughput literature analysis. Deftereos SN, Andronis C, Friedla EJ, Persidis A, Persidis A, Wiley interdisciplinary reviews. Systems biology and medicine 2011 3 323 34 10.1002/wsbm.147 21416632
5. Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data. Sirota M, Dudley JT, Kim J, Chiang AP, Morgan AA, Sweet-Cordero A, Sage J, Butte AJ, Science Translational Medicine 2011 3 96ra77 96ra77 10.1126/scitranslmed.3001318 21849665
6. Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease. Dudley JT, Sirota M, Shenoy M, Pai RK, Roedder S, Chiang AP, Morgan AA, Sarwal MM, Pasricha PJ, Butte AJ, Science Translational Medicine 2011 3 96ra76 96ra76 10.1126/scitranslmed.3002648 21849664
7. Drug repositioning for orphan diseases. Sardana D, Zhu C, Zhang M, Gudivada RC, Yang L, Jegga AG, Brief Bioinform 2011 12 346 356 10.1093/bib/bbr021 21504985
8. Use of genome-wide association studies for drug repositioning. Sanseau P, Agarwal P, Barnes MR, Pastinen T, Richards JB, Cardon LR, Mooser V, Nature Biotechnology 2012 30 317 320 10.1038/nbt.2151 22491277
9. Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis. Kinnings SL, Liu N, Buchmeier N, Tonge PJ, Xie L, Bourne PE, PLoS computational biology 2009 5 1000423 10.1371/journal.pcbi.1000423 19578428
10. A large-scale computational approach to drug repositioning. Li YY, An J, Jones SJM, Genome informatics. International Conference on Genome Informatics 2006 17 239 47 17503396
11. Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data. Sirota M, Dudley JT, Kim J, Chiang AP, Morgan AA, Sweet-Cordero A, Sage J, Butte AJ, Science Translational Medicine 2011 3 96ra77 96ra77 10.1126/scitranslmed.3001318 21849665
12. Systematic drug repositioning based on clinical side-effects. Yang L, Agarwal P, PloS one 2011 6 28025 10.1371/journal.pone.0028025 22205936
13. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M, Nucleic acids research 2008 36 901 6 18048412
14. Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. Klein TE, Chang JT, Cho MK, Easton KL, Fergerson R, Hewett M, Lin Z, Liu Y, Liu S, Oliver DE, Rubin DL, Shafa F, Stuart JM, Altman RB, The pharmacogenomics journal 2001 1 167 70 10.1038/sj.tpj.6500035 11908751 (Pubitemid 33756654)
15. PharmGKB: the Pharmacogenetics Knowledge Base. Hewett M, Oliver D, Rubin D, Easton K, Stuart J, Altman R, Klein T, Nucleic Acids Res 2002 30 163 165 10.1093/nar/30.1.163 11752281 (Pubitemid 34679530)
16. The Comparative Toxicogenomics Database: update 2011. Davis AP, King BL, Mockus S, Murphy CG, Saraceni-Richards C, Rosenstein M, Wiegers T, Mattingly CJ, Nucleic Acids Res 2011 39 1067 D1072 10.1093/nar/gkq813 20864448
17. A side effect resource to capture phenotypic effects of drugs. Kuhn M, Campillos M, Letunic I, Jensen LJ, Bork P, Molecular systems biology 2010 6 343 20087340
18. Somatomedin C and arginine: implicit connections between mutually isolated literatures. Swanson DR, Perspectives in biology and medicine 1990 33 157 86 2406696 (Pubitemid 20152760)
19. Literature Mining for the Discovery of Hidden Connections between Drugs, Genes and Diseases. Frijters R, Van Vugt M, Smeets R, Van Schaik R, De Vlieg J, Alkema W, PLoS Computational Biology 2010 6 1000943 10.1371/journal.pcbi.1000943 20885778
20. Literature mining, ontologies and information visualization for drug repurposing. Andronis C, Sharma A, Virvilis V, Deftereos S, Persidis A, Briefings in bioinformatics 2011 12 357 68 10.1093/bib/bbr005 21712342
21. Computational polypharmacology with text mining and ontologies. Plake C, Schroeder M, Current pharmaceutical biotechnology 2011 12 449 57 10.2174/138920111794480624 21133848
22. Chapter 11 Relationships in Medical Subject Headings. http://www.nlm.nih.gov/mesh/meshrels.html
23. Quantitative biomedical annotation using medical subject heading over-representation profiles (MeSHOPs). Cheung WA, Ouellette BF, Wasserman WW, BMC bioinformatics 2012 13 249 10.1186/1471-2105-13-249 23017167
24. Inferring novel gene-disease associations using medical subject heading over-representation profiles. Cheung WA, Ouellette BF, Wasserman WW, Genome medicine 2012 4 75 10.1186/gm376 23021552
25. The (un)targeted cancer kinome. Fedorov O, Müller S, Knapp S, Nature chemical biology 2010 6 166 169 20154661
26. Too many roads not taken. Edwards AM, Isserlin R, Bader GD, Frye SV, Willson TM, Yu FH, Nature 2011 470 163 5 10.1038/470163a 21307913
27. PREDICT: a method for inferring novel drug indications with application to personalized medicine. Gottlieb A, Stein GY, Ruppin E, Sharan R, Molecular systems biology 2011 7 496 21654673
28. The Impact of Multifunctional Genes on «Guilt by Association» Analysis. Gillis J, Pavlidis P, PLoS ONE 2011 6 17258 10.1371/journal.pone. 0017258 21364756
29. A CitationRank algorithm inheriting Google technology designed to highlight genes responsible for serious adverse drug reaction. Yang L, Xu L, He L, Bioinformatics 2009 25 2244 2250 10.1093/bioinformatics/btp369 19528085